EveryCat Health Foundation: The Cat Connection to Long Covid Part 2 With Dr Maggie Placer

Send us Fan Mailn Part 2 of my conversation with Dr. Maggie Placer from EveryCat Health Foundation, we continue our discussion of the One Health approach and the surprising connections between veterinary and human medicine.This episode explores how research that began with treating cats has contributed to a broader understanding of antiviral therapies and why researchers are now studying Remdesivir as a potential treatment for Long COVID in humans. While the research is ongoing, it highlights how collaboration across medical and veterinary fields can accelerate scientific discovery.Whether you're interested in rare diseases, infectious diseases, veterinary medicine, or emerging medical research, this conversation offers a fascinating look at how breakthroughs can cross the boundaries between species.If you missed Part 1, be sure to listen to the previous episode for the beginning of this conversation.Guest: Dr. Maggie Placer, EveryCat Health FoundationIn this episode:What One Health means in practiceHow feline antiviral research has informed human medicineWhy researchers are investigating antivirals for Long COVIDThe value of collaboration between veterinary and human healthcareThank you for listening to Rare Connection, where we connect patients, caregivers, clinicians, researchers, and advocates to educate, inspire, and advance awareness of rare diseases and emerging medical discoveSupport the show